171 related articles for article (PubMed ID: 22287766)
1. Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinoma.
Venton G; Ducournau A; Gross E; Lechevallier E; Rochwerger A; Curvale G; Zink JV; Salas S; Deville JL
Anticancer Res; 2012 Feb; 32(2):701-5. PubMed ID: 22287766
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
Yoshinaga A; Kamata S
Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy for Renal Cell Carcinoma.
Joshi R; Rawal S
JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
[TBL] [Abstract][Full Text] [Related]
4. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
[No Abstract] [Full Text] [Related]
5. Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
Hird AE; Chow E; Ehrlich L; Probyn L; Sinclair E; Yip D; Ko YJ
J Palliat Med; 2008 Oct; 11(8):1156-61. PubMed ID: 18980461
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
Zimmermann K; Schmittel A; Steiner U; Asemissen AM; Knoedler M; Thiel E; Miller K; Keilholz U
Oncology; 2009; 76(5):350-4. PubMed ID: 19321976
[TBL] [Abstract][Full Text] [Related]
7. [Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].
Morizawa Y; Momose H; Toyoshima Y; Takada S; Fujimoto K; Oyama N
Hinyokika Kiyo; 2013 Dec; 59(12):791-3. PubMed ID: 24419011
[TBL] [Abstract][Full Text] [Related]
8. Metastatic collecting duct carcinoma of the kidney treated with sunitinib.
Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: a case report.
Ricciardulli S; Del Biondo D; Cicero C; Leo G; Zeccolini G; Celia A
Urologia; 2015; 82(2):109-13. PubMed ID: 25050998
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sunitinib in patients with renal cell carcinoma with bone metastases.
Paule B; Brion N
Anticancer Res; 2010 Dec; 30(12):5165-8. PubMed ID: 21187506
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect?
Taussky D; Soulières D
Can J Urol; 2009 Apr; 16(2):4599-600. PubMed ID: 19364436
[TBL] [Abstract][Full Text] [Related]
12. Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.
Paglino C; Imarisio I; Ganini C; Morbini P; Vercelli A; Bregant C; Porta C
Future Oncol; 2012 Dec; 8(12):1605-12. PubMed ID: 23231522
[TBL] [Abstract][Full Text] [Related]
13. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
[TBL] [Abstract][Full Text] [Related]
14. Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
Basille D; Andrejak M; Bentayeb H; Kanaan M; Fournier C; Lecuyer E; Boutemy M; Garidi R; Douadi Y; Dayen C
Ann Pharmacother; 2010 Feb; 44(2):383-6. PubMed ID: 20118139
[TBL] [Abstract][Full Text] [Related]
15. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib.
Terakawa T; Miyake H; Kusuda Y; Fujisawa M
Urol Oncol; 2013 May; 31(4):493-8. PubMed ID: 21478036
[TBL] [Abstract][Full Text] [Related]
16. Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.
Vaz MA; Pachón V; Grande E; Ferreiro R; Carrato A
Anticancer Drugs; 2011 Sep; 22(8):817-21. PubMed ID: 21566523
[TBL] [Abstract][Full Text] [Related]
17. Sunitinib in patients with metastatic renal cell carcinoma.
Motzer RJ; Rini BI; Bukowski RM; Curti BD; George DJ; Hudes GR; Redman BG; Margolin KA; Merchan JR; Wilding G; Ginsberg MS; Bacik J; Kim ST; Baum CM; Michaelson MD
JAMA; 2006 Jun; 295(21):2516-24. PubMed ID: 16757724
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH
Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162
[TBL] [Abstract][Full Text] [Related]
19. Long-term response with sunitinib for metastatic renal cell carcinoma.
Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
[TBL] [Abstract][Full Text] [Related]
20. Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.
Rini BI; Shaw V; Rosenberg JE; Kim ST; Chen I
Clin Genitourin Cancer; 2006 Dec; 5(3):232-4. PubMed ID: 17239278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
